Clinical Trial Update: NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on NK donor lymphocyte infusion following HLA-haploidentical HSCT; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia Myeloid Acute
• Lymphoma
• Myelodysplastic Syndromes
• Neuroblastoma
• Precursor Cell Lymphoblastic Leukemia-lymphoma
• Rhabdomyosarcoma

Drugs mentioned

• NK DLI after HLA-Haploidentical HSCT

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 1, Phase 2 | Status: COMPLETED